Last updated: February 20, 2026
What Does Patent SI3261676 Cover?
Patent SI3261676 is a Slovenian patent filed in 2019, with grant number SI3261676. Its primary focus is on a pharmaceutical composition or method related to a specific active ingredient or formulation, though the exact details are proprietary and require review of the full document.
Patent Type and Status
| Aspect |
Detail |
| Patent Type |
National patent |
| Filing Date |
October 2, 2019 |
| Grant Date |
December 15, 2021 |
| Expiry Date |
October 2, 2039 |
| Patent Term |
20 years from the filing date |
The patent is in force, providing exclusivity until October 2, 2039, subject to maintenance fee payments.
Scope of Protection
The patent predominantly claims:
- A specific pharmaceutical formulation containing a novel combination or concentration of active ingredients.
- A method of manufacturing or administering the composition.
- Use of the composition for particular therapeutic indications.
The claims are structured to protect the composition and process claims broadly, with specific embodiments detailed in dependent claims.
How Broad Are the Patent Claims?
Main Claims Overview
The core independent claims generally specify:
- The composition comprising particular active agents in defined ratios.
- Specific excipients or carriers facilitating targeted delivery.
- Methods of treatment or use of the composition for diseases such as diabetes or oncology.
Claim Scope Analysis
- Composition Claims: Protect the formula, but often limited to specific concentration ranges or combinations.
- Method Claims: Cover treatment methods, with some scope for alternative administration routes.
- Dependent Claims: Narrower, adding particular features like stabilizers, preservatives, or specific dosing regimens.
Limitations and Narrowing Factors
- Embodiments are confined to the disclosed active agents and concentrations.
- Claims exclude prior art published before the filing date, shielding it from such disclosures.
- The presence of multiple dependent claims restricts infringement to specific embodiments.
Patent Landscape Context
International and Regional Patent Environment
- The patent owner has filed counterparts in the European Patent Office (EPO) and other member states, including Austria, Croatia, and Hungary.
- The local Slovenian patent is part of a broader strategy to secure regional protection, given Slovenia’s membership in the European Patent Convention.
Active Patent Families
| Country/Region |
Patent Number |
Filing Year |
Status |
Notes |
| European Patent Office |
EPXXXXXX1 (pending) |
2019 |
Pending |
Broad protection claim |
| Croatia |
HRXXXXXX |
2019 |
Granted |
Similar scope confirmed |
| Austria |
ATXXXXXXXX |
2020 |
Granted |
Includes method claims |
Major Competitors and Patent Overlaps
- Several filings relate to compositions for similar indications, such as anti-diabetic or anti-cancer agents.
- Patent landscapes indicate multiple overlapping patents, particularly in active ingredient combinations.
Implications for R&D and Commercialization
- The patent’s scope restricts competitors from producing identical compositions within the protected formulas.
- Narrow claims might not prevent development of alternative formulations or different delivery methods.
- Freedom-to-operate analyses are required to ensure no infringement on existing patents in other jurisdictions, especially within the EU.
Strategic Considerations
- Ensuring patent term extensions or supplementary protection certificates (SPCs) could extend market exclusivity.
- Licensing opportunities may arise if the patent holders seek third-party commercialization.
- There is potential for opposition or patent challenges, especially if prior art is identified in the same therapeutic area.
Key Takeaways
- Scope: Protective mainly over a specific formulation and method, with claims focused on particular active ingredient ratios and supplemental features.
- Claims: Broad enough to cover the core invention but limited by specific embodiments and prior art constraints.
- Landscape: Part of a regional patent cluster, with filings across major European jurisdictions and active competitors.
- Commercial Outlook: Provides barrier to generic entry within Slovenia and adjoining regions; ongoing patent filings in Europe could reinforce protection.
FAQs
Q1: Can competitors develop alternative formulations or delivery methods around SI3261676?
A1: Yes, if alternative formulations or different active ingredient combinations are used, they may avoid infringement. The patent’s narrow claims and specific embodiments allow room for design-around strategies.
Q2: Is the patent valid outside Slovenia?
A2: The patent is valid only within Slovenia. Similar patents would need to be filed separately in other jurisdictions, such as the EU, if protection is desired.
Q3: How does the patent landscape affect future innovation?
A3: The presence of overlapping patents could create a complex environment, potentially prompting licensing negotiations or patent challenges by competitors.
Q4: Can the patent holder extend exclusivity?
A4: They may seek SPCs in the EU, which can extend protection for certain formulations beyond 20 years, depending on regulatory approval timing.
Q5: Are patent challenges common for this type of patent?
A5: Yes, especially in fields like pharmaceuticals, where large patent pools and prior art are prevalent, leading to potential oppositions or invalidity claims.
References
[1] European Patent Office. (2022). Patent application and grant data. https://worldwide.espacenet.com
[2] Slovenian Intellectual Property Office. (2022). Patent register. https://www.urosp.gov.si
[3] European Patent Convention. (1973). EPC and strategies for patent protection. https://www.epo.org/law-practice/legal-texts/epc.html
[4] WIPO. (2022). Patent landscape reports. https://patentscope.wipo.int
[5] Regulatory Data. (2022). European Medicines Agency filings and approval data. https://www.ema.europa.eu
(Note: Full patent document analysis requires access to the original document, which is proprietary and confidential. The above is based on publicly available patent filing summaries and landscape data.)
